Home Back Pain Page 3

Back Pain

Wink News
Back Pain

Wink News

AmericanChiro -
0
New Atlas
Back Pain

New Atlas

AmericanChiro -
0
The 9 Best Mattresses for Back Pain of 2023 | Tested by PEOPLE – PEOPLE
Back Pain

The 9 Best Mattresses for Back Pain of 2023 | Tested by PEOPLE – PEOPLE

AmericanChiro -
0
The Best Office Chairs for Back Pain that Support You While Working – Forbes
Back Pain

The Best Office Chairs for Back Pain that Support You While Working – Forbes

AmericanChiro -
0
Back Pain Natural Remedy – The Yucatan Times The Yucatan Times (
Back Pain

Back Pain Natural Remedy – The Yucatan Times The Yucatan Times (

AmericanChiro -
0
J.D. Martinez Regrets Putting Off Back Pain – Yardbarker
Back Pain

J.D. Martinez Regrets Putting Off Back Pain – Yardbarker

AmericanChiro -
0
A Specialized Approach for Neck and Back Pain: Dr. Scott Raub… – Vail Daily 825706221773 Dr. Scott Raub helps people with severe and prolonged neck and back pain by treating the source of pain, working within limitations, and maximising potentials. As a physiatrist, he specializes at Vail-Summit Orthopaedics & Neurosurgery in accurately diagnosing musculoskeletal disorders through a variety of clinical exams, imaging and other diagnostic tests. He then treats them with nonsurgical interventions that include multiple modalities ranging from injections and physical therapy. Dr. Scott Raub, MD, joined Vail-Summit Orthopaedics & Neurosurgery as the first physiatrist in Eagle County in 1999. It is often difficult to determine the exact cause of spinal problems due to the dense network of nerves. This is especially true when the pain originates from multiple areas. Dr. Raub specializes on determining the source of pain. This is done by examining patients and using diagnostic tools such as xrays, MRIs or live fluoroscopic images. He said that an MRI often does not show where the pain originates. It doesn’t have a “red arrow” indicating, “this is what hurts.” We use it along with a physical and a history exam. “Then we can make a plausible diagnosis of the pain generator.” Dr. Raub treats many patients who have already tried physical therapy and chiropractic adjustments, as well as multiple medications. He is quick to point out the fact that most spinal conditions don’t require surgery. He takes a collaborative approach and often incorporates spinal injections as well as a community of back-pain experts (physical therapists massage therapists chiropractors personal trainers etc.). ). Support Local Journalism Donate “My philosophy is to really improve symptoms,” he explained, describing his approach multimodal. “I always stress that injection results will never be a permanent solution, because they do not change or improve the anatomy. It’s important that people are educated to have realistic expectations once they start a treatment algorithm for spine pain. Dr. Raub uses a holistic (and realistic approach) to help patients optimize their activities, while making reasonable compromises. For example, taking the time to exercise regularly and reducing risks by avoiding crowded runs on skis or biking, or reducing speed during skiing or biking. Dr. Scott Raub specializes in accurately diagnosing musculoskeletal conditions through a range of clinical exams, images and other diagnostic tests. “One of the most important things you can tell people is that they don’t have an evil problem that will kill them. The vast majority of people are going to improve.” He said that it is important to demystify the pain, validate that there is a cause for your back pain and remind them that they are not going to be in a wheel chair. “There are some things we can improve the situation.” He encourages his patients to be a part of the solution both mentally and behaviorally. He said that the patient must also be willing to accept the treatment prescribed. This means modifying lifestyle risks, such as smoking, obesity or a sedentary life style, and setting realistic expectations. For example, a 65 year old can’t expect to be able to bounce around in a terrain park without back pain. Dr. Raub supports a youthful attitude. He calls it “a powerful tool for achieving positive results for spinal patients.” After completing his residency in physical medicine, rehabilitation, and pain management in 1994, and his fellowship in sports and exercise medicine in 1995, he joined VSON in 1999 as the first physiatrist to work in Eagle County. “It’s been the best part in my life, living and working here,” said he. “The people with whom I work are wonderful — they are educated and sophisticated people who are active and age well. The patients I take care of are fascinating individuals. “They’re here because the want to be here.” Dr. Raub, who is a skier, outdoor enthusiast, and a member of the VSON team, understands how important it is for his patients to maintain an active lifestyle. He and the VSON team are focused on helping people get back to what they love. “At VSON we have sub-specialty doctors who are top-notch and have the intellect, technology, and ability to work in a big city, if we chose to, but we value the mountain lifestyle,” said he. “Our patients receive big-city care within a small-town setting.”
Back Pain

A Specialized Approach for Neck and Back Pain: Dr. Scott Raub… – Vail Daily 825706221773 Dr. Scott Raub helps people with severe and prolonged neck and back pain by treating the source of pain, working within limitations, and maximising potentials. As a physiatrist, he specializes at Vail-Summit Orthopaedics & Neurosurgery in accurately diagnosing musculoskeletal disorders through a variety of clinical exams, imaging and other diagnostic tests. He then treats them with nonsurgical interventions that include multiple modalities ranging from injections and physical therapy. Dr. Scott Raub, MD, joined Vail-Summit Orthopaedics & Neurosurgery as the first physiatrist in Eagle County in 1999. It is often difficult to determine the exact cause of spinal problems due to the dense network of nerves. This is especially true when the pain originates from multiple areas. Dr. Raub specializes on determining the source of pain. This is done by examining patients and using diagnostic tools such as xrays, MRIs or live fluoroscopic images. He said that an MRI often does not show where the pain originates. It doesn’t have a “red arrow” indicating, “this is what hurts.” We use it along with a physical and a history exam. “Then we can make a plausible diagnosis of the pain generator.” Dr. Raub treats many patients who have already tried physical therapy and chiropractic adjustments, as well as multiple medications. He is quick to point out the fact that most spinal conditions don’t require surgery. He takes a collaborative approach and often incorporates spinal injections as well as a community of back-pain experts (physical therapists massage therapists chiropractors personal trainers etc.). ). Support Local Journalism Donate “My philosophy is to really improve symptoms,” he explained, describing his approach multimodal. “I always stress that injection results will never be a permanent solution, because they do not change or improve the anatomy. It’s important that people are educated to have realistic expectations once they start a treatment algorithm for spine pain. Dr. Raub uses a holistic (and realistic approach) to help patients optimize their activities, while making reasonable compromises. For example, taking the time to exercise regularly and reducing risks by avoiding crowded runs on skis or biking, or reducing speed during skiing or biking. Dr. Scott Raub specializes in accurately diagnosing musculoskeletal conditions through a range of clinical exams, images and other diagnostic tests. “One of the most important things you can tell people is that they don’t have an evil problem that will kill them. The vast majority of people are going to improve.” He said that it is important to demystify the pain, validate that there is a cause for your back pain and remind them that they are not going to be in a wheel chair. “There are some things we can improve the situation.” He encourages his patients to be a part of the solution both mentally and behaviorally. He said that the patient must also be willing to accept the treatment prescribed. This means modifying lifestyle risks, such as smoking, obesity or a sedentary life style, and setting realistic expectations. For example, a 65 year old can’t expect to be able to bounce around in a terrain park without back pain. Dr. Raub supports a youthful attitude. He calls it “a powerful tool for achieving positive results for spinal patients.” After completing his residency in physical medicine, rehabilitation, and pain management in 1994, and his fellowship in sports and exercise medicine in 1995, he joined VSON in 1999 as the first physiatrist to work in Eagle County. “It’s been the best part in my life, living and working here,” said he. “The people with whom I work are wonderful — they are educated and sophisticated people who are active and age well. The patients I take care of are fascinating individuals. “They’re here because the want to be here.” Dr. Raub, who is a skier, outdoor enthusiast, and a member of the VSON team, understands how important it is for his patients to maintain an active lifestyle. He and the VSON team are focused on helping people get back to what they love. “At VSON we have sub-specialty doctors who are top-notch and have the intellect, technology, and ability to work in a big city, if we chose to, but we value the mountain lifestyle,” said he. “Our patients receive big-city care within a small-town setting.”

AmericanChiro -
0
Global Chronic Lower Back pain Treatment Market Report 2023… – GlobeNewswire 825706221773 Dublin, April 25, 2023 (GLOBE NEWSWIRE) — The “Global Chronic Lower Back Pain Treatment Market Report and Forecast 2023-2031” report has been added to ResearchAndMarkets.com’s offering. The global chronic lower-back pain treatment market was valued at USD 7,9 billion in 2022. It is projected to grow by 4.90% CAGR during the forecast period 2023-2031 and reach a value USD 12,38 billion by 2031. The demand for effective treatment is increasing due to the prevalence of chronic lower-back pain. This is caused by factors like obesity, sedentary lifestyles and poor posture. Market growth is also expected to be driven by other factors, including government initiatives, aging populations, and growing awareness of pain management. The growth of the chronic lower-back pain treatment market has been largely attributed to technological advancements. The development of novel treatments, such as neuromodulation and minimally invasive procedures, has made chronic lower back pain treatment more effective and less invasive. This has helped to expand the reach of chronic back pain treatment, and help meet the growing demand. As awareness of chronic lower-back pain issues grows, and as new treatment options and technology are developed to meet people’s needs, the chronic lower-back pain treatment market will continue to grow. There are still significant barriers in accessing chronic lower-back pain treatment, especially in low-and middle-income countries where healthcare services are often limited. There are global efforts underway to improve access to chronic back pain treatment and address these barriers. Chronic Lower back Pain Epidemiology A significant percentage of the world’s population suffers from chronic lower back pain. The prevalence is estimated to be between 20-30% among adults. It is one the leading causes for disability in the world and can have a significant effect on the quality and productivity of those affected. As the global population grows older, chronic lower back problems are expected to increase. Lifestyle factors such as obesity and sedentary behavior also contribute to chronic lower back issues. Market Segments for Chronic Lower Back Pain Treatment The market can be segmented by pain type, diagnosis and treatment channel as well as major regions. Market Segmentation by Pain Type Discogenic Pain Lumbar Spinal Stenosis Sacroiliac Pain Facet- Joint Pain Radicular Pain Muscular Pain Other Market Analysis by Diagnosis Clinical History Physical Examination Image Guidelines Other Market Segmentation by Treatment Channel Public Private Investigators Market Analysis by Region North America United States of America Canada Europe United Kingdom Germany France Italy Other Asia Pacific China Japan India ASEAN Australia Other Latin America Brazil Argentina Mexico Other Middle East and Africa Saudi Arabia United Arab Emirates Nigeria South Africa Other Market Analysis for Chronic Lower Back Pain Treatment The global chronic lower-back pain treatment market has grown significantly over the last few years. This growth is attributed to factors such as an aging population, increasing awareness of pain management and the increasing prevalence chronic lower-back pain. The increasing prevalence of chronic back pain is a key driver for growth in the chronic back pain treatment market. North America currently holds a large share of the global chronic lower back pain market. The large market share of the region is due to factors such as a high incidence of chronic lower back problems, a well-established health care infrastructure, and a strong investment in R&D. The market growth in North America is also driven by the increasing adoption of novel therapies, as well as minimally invasive procedures. Europe is a major market for chronic lower-back pain treatment. Countries like the United Kingdom, Germany and France are leading the charge. The growth of the market in this region is attributed to factors such as a large number of people, increased awareness about chronic lower-back pain, and government initiatives addressing chronic lower-back pain. The region also has a well-established health care system that supports the delivery chronic lower back pain treatments. Asia Pacific is also experiencing significant growth on the chronic lower back treatment market. The growth of the market in this region is largely due to factors such as a large and growing population, increased awareness of chronic lower-back pain, and the increasing adoption of novel therapies and minimally-invasive procedures. Government initiatives to address chronic back pain concerns also help to drive the market growth in the region. Key players in the global chronic lower back pain treatment market The report provides an in-depth analysis of the key players operating in the chronic lower back treatment market. This includes their business overview, their product portfolio, and recent developments. It also includes a financial analysis. Some of the key players operating in the chronic lower back pain treatment market include: Johnson & Johnson Pfizer Inc Sanofi S.A Merck & Co., Inc Medtronic plc Endo International plc Boston Scientific Corporation Koninklijke Philips N.V Karl Storz SE & Co. KG Stryker Corporation Key Attributes Report Attribute Details No. No. 147 Forecast Period 2023 – 2031 Estimated Market value (USD) by 2023 $8.29 Billion Forecasted Market Value in USD by 2031 $12.38 Billion Compound Annual Growth Rate 4.9% Areas covered Global Key topics covered: 1 Preface 2 Research Methodology 3 Executive Summary 4 Chronic Lower back Pain Overview 5 Patient Profile 6 Current Scenario Evaluation & Regulatory Framework 6.1 Emerging therapies and clinical trials 6.2 Patent Landscape 6.2.1 Patent Overview Patent Status and Expiration Timelines from Drug Research to Commercial Launch 6.2.1.3 New Drug Applications Documentation and Approval process Cost of Treatment 6.4 Regulatory Framework 6.4.1 Regulatory Overview 6.4.1.1 US FDA 6.4.1.2 EU EMA 6.4.1.3 INDIA CDS JAPAN PMDA Other 7 Challenges & Unmet Needs 7.1 Treatment Pathway Challenges 7.2 Compliance Analysis and Drop-Out Analysis 7.3 Awareness and prevention Gaps 8 Global Chronic Low Back Pain Treatment Market 9 North America Chronic Lower Back Pain Treatment Market 10 Europe Chronic Lower back Pain Treatment Market 11 Asia Pacific Chronic Low Back Pain Treatment Market 12 Latin America Chronic Low Back Pain Treatment Market 13 Middle East & Africa Chronic Lower Back pain Treatment Market 14 Global Chronic Low Back Pain Treatment Market Dynamics 15 Supplier Landscape 16 Global Chronic Low Back Pain Treatment Market – Drug Distribution Model (Additional insights) 17 Payment Options (Additional Insights) For more information about this report visit https://www.researchandmarkets.com/r/wsv29v About ResearchAndMarkets.com ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide the latest data on the international and regional markets, key industry sectors, top companies, new product and trend information. Attachment Global Chronic Lower Back pain Treatment Market
Back Pain

Global Chronic Lower Back pain Treatment Market Report 2023… – GlobeNewswire 825706221773 Dublin, April 25, 2023 (GLOBE NEWSWIRE) — The “Global Chronic Lower Back Pain Treatment Market Report and Forecast 2023-2031” report has been added to ResearchAndMarkets.com’s offering. The global chronic lower-back pain treatment market was valued at USD 7,9 billion in 2022. It is projected to grow by 4.90% CAGR during the forecast period 2023-2031 and reach a value USD 12,38 billion by 2031. The demand for effective treatment is increasing due to the prevalence of chronic lower-back pain. This is caused by factors like obesity, sedentary lifestyles and poor posture. Market growth is also expected to be driven by other factors, including government initiatives, aging populations, and growing awareness of pain management. The growth of the chronic lower-back pain treatment market has been largely attributed to technological advancements. The development of novel treatments, such as neuromodulation and minimally invasive procedures, has made chronic lower back pain treatment more effective and less invasive. This has helped to expand the reach of chronic back pain treatment, and help meet the growing demand. As awareness of chronic lower-back pain issues grows, and as new treatment options and technology are developed to meet people’s needs, the chronic lower-back pain treatment market will continue to grow. There are still significant barriers in accessing chronic lower-back pain treatment, especially in low-and middle-income countries where healthcare services are often limited. There are global efforts underway to improve access to chronic back pain treatment and address these barriers. Chronic Lower back Pain Epidemiology A significant percentage of the world’s population suffers from chronic lower back pain. The prevalence is estimated to be between 20-30% among adults. It is one the leading causes for disability in the world and can have a significant effect on the quality and productivity of those affected. As the global population grows older, chronic lower back problems are expected to increase. Lifestyle factors such as obesity and sedentary behavior also contribute to chronic lower back issues. Market Segments for Chronic Lower Back Pain Treatment The market can be segmented by pain type, diagnosis and treatment channel as well as major regions. Market Segmentation by Pain Type Discogenic Pain Lumbar Spinal Stenosis Sacroiliac Pain Facet- Joint Pain Radicular Pain Muscular Pain Other Market Analysis by Diagnosis Clinical History Physical Examination Image Guidelines Other Market Segmentation by Treatment Channel Public Private Investigators Market Analysis by Region North America United States of America Canada Europe United Kingdom Germany France Italy Other Asia Pacific China Japan India ASEAN Australia Other Latin America Brazil Argentina Mexico Other Middle East and Africa Saudi Arabia United Arab Emirates Nigeria South Africa Other Market Analysis for Chronic Lower Back Pain Treatment The global chronic lower-back pain treatment market has grown significantly over the last few years. This growth is attributed to factors such as an aging population, increasing awareness of pain management and the increasing prevalence chronic lower-back pain. The increasing prevalence of chronic back pain is a key driver for growth in the chronic back pain treatment market. North America currently holds a large share of the global chronic lower back pain market. The large market share of the region is due to factors such as a high incidence of chronic lower back problems, a well-established health care infrastructure, and a strong investment in R&D. The market growth in North America is also driven by the increasing adoption of novel therapies, as well as minimally invasive procedures. Europe is a major market for chronic lower-back pain treatment. Countries like the United Kingdom, Germany and France are leading the charge. The growth of the market in this region is attributed to factors such as a large number of people, increased awareness about chronic lower-back pain, and government initiatives addressing chronic lower-back pain. The region also has a well-established health care system that supports the delivery chronic lower back pain treatments. Asia Pacific is also experiencing significant growth on the chronic lower back treatment market. The growth of the market in this region is largely due to factors such as a large and growing population, increased awareness of chronic lower-back pain, and the increasing adoption of novel therapies and minimally-invasive procedures. Government initiatives to address chronic back pain concerns also help to drive the market growth in the region. Key players in the global chronic lower back pain treatment market The report provides an in-depth analysis of the key players operating in the chronic lower back treatment market. This includes their business overview, their product portfolio, and recent developments. It also includes a financial analysis. Some of the key players operating in the chronic lower back pain treatment market include: Johnson & Johnson Pfizer Inc Sanofi S.A Merck & Co., Inc Medtronic plc Endo International plc Boston Scientific Corporation Koninklijke Philips N.V Karl Storz SE & Co. KG Stryker Corporation Key Attributes Report Attribute Details No. No. 147 Forecast Period 2023 – 2031 Estimated Market value (USD) by 2023 $8.29 Billion Forecasted Market Value in USD by 2031 $12.38 Billion Compound Annual Growth Rate 4.9% Areas covered Global Key topics covered: 1 Preface 2 Research Methodology 3 Executive Summary 4 Chronic Lower back Pain Overview 5 Patient Profile 6 Current Scenario Evaluation & Regulatory Framework 6.1 Emerging therapies and clinical trials 6.2 Patent Landscape 6.2.1 Patent Overview Patent Status and Expiration Timelines from Drug Research to Commercial Launch 6.2.1.3 New Drug Applications Documentation and Approval process Cost of Treatment 6.4 Regulatory Framework 6.4.1 Regulatory Overview 6.4.1.1 US FDA 6.4.1.2 EU EMA 6.4.1.3 INDIA CDS JAPAN PMDA Other 7 Challenges & Unmet Needs 7.1 Treatment Pathway Challenges 7.2 Compliance Analysis and Drop-Out Analysis 7.3 Awareness and prevention Gaps 8 Global Chronic Low Back Pain Treatment Market 9 North America Chronic Lower Back Pain Treatment Market 10 Europe Chronic Lower back Pain Treatment Market 11 Asia Pacific Chronic Low Back Pain Treatment Market 12 Latin America Chronic Low Back Pain Treatment Market 13 Middle East & Africa Chronic Lower Back pain Treatment Market 14 Global Chronic Low Back Pain Treatment Market Dynamics 15 Supplier Landscape 16 Global Chronic Low Back Pain Treatment Market – Drug Distribution Model (Additional insights) 17 Payment Options (Additional Insights) For more information about this report visit https://www.researchandmarkets.com/r/wsv29v About ResearchAndMarkets.com ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide the latest data on the international and regional markets, key industry sectors, top companies, new product and trend information. Attachment Global Chronic Lower Back pain Treatment Market

AmericanChiro -
0
Global Chronic Lower Back pain Treatment Market Report 2023 – Growing Government Initiatives, Aging Populations, and Growing Awareness about Pain Management Drive 4.9% annual Growth – Yahoo Finance 825706221773 Company Logo Global Chronic Lower Back pain Treatment Market Global Chronic Lower Back pain Treatment Market Dublin, April 25, 2023 (GLOBE NEWSWIRE) — The “Global Chronic Lower Back Pain Treatment Market Report and Forecast 2023-2031” report has been added to ResearchAndMarkets.com’s offering. The global chronic lower-back pain treatment market was valued at USD 7,9 billion in 2022. It is projected to grow by 4.90% CAGR during the forecast period 2023-2031 and reach a value USD 12,38 billion by 2031. The demand for effective treatment is increasing due to the prevalence of chronic lower-back pain. This is caused by factors like obesity, sedentary lifestyles and poor posture. Market growth is also expected to be driven by other factors, including government initiatives, an ageing population, and a growing awareness of pain management. The growth of the chronic lower-back pain treatment market has been largely attributed to technological advancements. The development of novel treatments, such as neuromodulation and minimally invasive procedures, has made chronic lower back pain treatment more effective and less invasive. This has helped to expand the reach of chronic back pain treatment, and help meet the growing demand. As awareness of chronic lower-back pain issues grows, and as new treatment options and technology are developed to meet people’s needs, the chronic lower-back pain treatment market will continue to grow. There are still significant barriers in accessing chronic lower-back pain treatment, especially in low-and middle-income countries where healthcare services are often limited. There are global efforts underway to improve access to chronic back pain treatment and address these barriers. Chronic Lower back Pain Epidemiology A significant percentage of the world’s population suffers from chronic lower back pain. The prevalence is estimated to be between 20-30% among adults. It is a leading cause of disability in the world and can have a significant effect on the quality and productivity of those affected. As the global population grows older, chronic lower back problems are expected to increase. Lifestyle factors such as obesity and sedentary behavior also contribute to chronic lower back issues. Market Segments for Chronic Lower Back Pain Treatment The market can be segmented by pain type, diagnosis and treatment channel as well as major regions. Market Segmentation by Pain Type Discogenic Pain Lumbar Spinal Stenosis Sacroiliac Pain Facet- Joint Pain Radicular Pain Muscular Pain Other Market Analysis by Diagnosis Clinical History Physical Examination Image Guidelines Other Market Segmentation by Treatment Channel Public Private Investigators Market Analysis by Region North America United States of America Canada Europe United Kingdom Germany France Italy Other Asia Pacific China Japan India ASEAN Australia Other Latin America Brazil Argentina Mexico Other Middle East and Africa Saudi Arabia United Arab Emirates Nigeria South Africa Other Market Analysis for Chronic Lower Back Pain Treatment The global chronic lower-back pain treatment market has grown significantly over the last few years. This growth is attributed to factors such as an aging population, increasing awareness of pain management and the increasing prevalence chronic lower-back pain. The increasing prevalence of chronic back pain is a key driver for growth in the chronic back pain treatment market. North America currently holds a large share of the global chronic lower back pain market. The large market share of the region is due to factors such as a high incidence of chronic lower back problems, a well-established health care infrastructure, and a strong investment in R&D. The market growth in North America is also driven by the increasing adoption of novel therapies, as well as minimally invasive procedures. Europe is a major market for chronic lower-back pain treatment. Countries like the United Kingdom, Germany and France are leading the charge. The growth of the market in this region is attributed to factors such as a large number of people, increased awareness about chronic lower-back pain, and government initiatives addressing chronic lower-back pain. The region also has a well-established health care system that supports the delivery chronic lower back pain treatments. Asia Pacific is also experiencing significant growth on the chronic lower back treatment market. The growth of the market in this region is largely due to factors such as the large population base of the region, increased awareness of chronic lower-back pain, and an increasing adoption of novel therapies and minimally-invasive procedures. Government initiatives to address chronic back pain concerns also help to drive the market growth in the region. Key players in the global chronic lower back pain treatment market The report provides an in-depth analysis of the key players operating in the chronic lowerback pain treatment market. This includes their business overview, their product portfolio, the latest developments, and a financial analysis. Some of the key players operating in the chronic lower back pain treatment market include: Key Attributes Report Attribute Details No. No. 147 Forecast Period 2023 – 2031 Estimated Market value (USD) by 2023 $8.29 Billion Forecasted Market Value in USD by 2031 $12.38 Billion Compound Annual Growth Rate 4.9% Areas covered Global Key topics covered: 1 Preface 2 Research Methodology 3 Executive Summary 4 Chronic Lower back Pain Overview 5 Patient Profile 6 Current Scenario Evaluation & Regulatory Framework 6.1 Emerging therapies and clinical trials 6.2 Patent Landscape 6.2.1 Patent Overview 6.2.1.1 Patent Status & Expiry Timelines from Drug Research to Commercial Launch New Drug Application Documentation and Approval process Cost of Treatment 6.4 Regulatory Framework 6.4.1 Regulatory Overview 6.4.1.1 US FDA 6.4.1.2 EU EMA 6.4.1.3 INDIA CDS JAPAN PMDA Other 7 Challenges & Unmet Needs 7.1 Treatment Pathway Challenges 7.2 Compliance Analysis and Drop-Out Analysis 7.3 Awareness and prevention Gaps 8 Global Chronic Low Back Pain Treatment Market 9 North America Chronic Lower Back Pain Treatment Market 10 Europe Chronic Lower back Pain Treatment Market 11 Asia Pacific Chronic Low Back Pain Treatment Market 12 Latin America Chronic Low Back Pain Treatment Market 13 Middle East & Africa Chronic Lower Back pain Treatment Market 14 Global Chronic Low Back Pain Treatment Market Dynamics 15 Supplier Landscape 16 Global Chronic Low Back Pain Treatment Market – Drug Distribution Model (Additional insights) 17 Payment Options (Additional Insights) For more information about this report visit https://www.researchandmarkets.com/r/wsv29v About ResearchAndMarkets.com ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide the latest data on the international and regional markets, key industry sectors, top companies, new product and trend information. Attachment CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Back Pain

Global Chronic Lower Back pain Treatment Market Report 2023 – Growing Government Initiatives, Aging Populations, and Growing Awareness about Pain Management Drive 4.9% annual Growth – Yahoo Finance 825706221773 Company Logo Global Chronic Lower Back pain Treatment Market Global Chronic Lower Back pain Treatment Market Dublin, April 25, 2023 (GLOBE NEWSWIRE) — The “Global Chronic Lower Back Pain Treatment Market Report and Forecast 2023-2031” report has been added to ResearchAndMarkets.com’s offering. The global chronic lower-back pain treatment market was valued at USD 7,9 billion in 2022. It is projected to grow by 4.90% CAGR during the forecast period 2023-2031 and reach a value USD 12,38 billion by 2031. The demand for effective treatment is increasing due to the prevalence of chronic lower-back pain. This is caused by factors like obesity, sedentary lifestyles and poor posture. Market growth is also expected to be driven by other factors, including government initiatives, an ageing population, and a growing awareness of pain management. The growth of the chronic lower-back pain treatment market has been largely attributed to technological advancements. The development of novel treatments, such as neuromodulation and minimally invasive procedures, has made chronic lower back pain treatment more effective and less invasive. This has helped to expand the reach of chronic back pain treatment, and help meet the growing demand. As awareness of chronic lower-back pain issues grows, and as new treatment options and technology are developed to meet people’s needs, the chronic lower-back pain treatment market will continue to grow. There are still significant barriers in accessing chronic lower-back pain treatment, especially in low-and middle-income countries where healthcare services are often limited. There are global efforts underway to improve access to chronic back pain treatment and address these barriers. Chronic Lower back Pain Epidemiology A significant percentage of the world’s population suffers from chronic lower back pain. The prevalence is estimated to be between 20-30% among adults. It is a leading cause of disability in the world and can have a significant effect on the quality and productivity of those affected. As the global population grows older, chronic lower back problems are expected to increase. Lifestyle factors such as obesity and sedentary behavior also contribute to chronic lower back issues. Market Segments for Chronic Lower Back Pain Treatment The market can be segmented by pain type, diagnosis and treatment channel as well as major regions. Market Segmentation by Pain Type Discogenic Pain Lumbar Spinal Stenosis Sacroiliac Pain Facet- Joint Pain Radicular Pain Muscular Pain Other Market Analysis by Diagnosis Clinical History Physical Examination Image Guidelines Other Market Segmentation by Treatment Channel Public Private Investigators Market Analysis by Region North America United States of America Canada Europe United Kingdom Germany France Italy Other Asia Pacific China Japan India ASEAN Australia Other Latin America Brazil Argentina Mexico Other Middle East and Africa Saudi Arabia United Arab Emirates Nigeria South Africa Other Market Analysis for Chronic Lower Back Pain Treatment The global chronic lower-back pain treatment market has grown significantly over the last few years. This growth is attributed to factors such as an aging population, increasing awareness of pain management and the increasing prevalence chronic lower-back pain. The increasing prevalence of chronic back pain is a key driver for growth in the chronic back pain treatment market. North America currently holds a large share of the global chronic lower back pain market. The large market share of the region is due to factors such as a high incidence of chronic lower back problems, a well-established health care infrastructure, and a strong investment in R&D. The market growth in North America is also driven by the increasing adoption of novel therapies, as well as minimally invasive procedures. Europe is a major market for chronic lower-back pain treatment. Countries like the United Kingdom, Germany and France are leading the charge. The growth of the market in this region is attributed to factors such as a large number of people, increased awareness about chronic lower-back pain, and government initiatives addressing chronic lower-back pain. The region also has a well-established health care system that supports the delivery chronic lower back pain treatments. Asia Pacific is also experiencing significant growth on the chronic lower back treatment market. The growth of the market in this region is largely due to factors such as the large population base of the region, increased awareness of chronic lower-back pain, and an increasing adoption of novel therapies and minimally-invasive procedures. Government initiatives to address chronic back pain concerns also help to drive the market growth in the region. Key players in the global chronic lower back pain treatment market The report provides an in-depth analysis of the key players operating in the chronic lowerback pain treatment market. This includes their business overview, their product portfolio, the latest developments, and a financial analysis. Some of the key players operating in the chronic lower back pain treatment market include: Key Attributes Report Attribute Details No. No. 147 Forecast Period 2023 – 2031 Estimated Market value (USD) by 2023 $8.29 Billion Forecasted Market Value in USD by 2031 $12.38 Billion Compound Annual Growth Rate 4.9% Areas covered Global Key topics covered: 1 Preface 2 Research Methodology 3 Executive Summary 4 Chronic Lower back Pain Overview 5 Patient Profile 6 Current Scenario Evaluation & Regulatory Framework 6.1 Emerging therapies and clinical trials 6.2 Patent Landscape 6.2.1 Patent Overview 6.2.1.1 Patent Status & Expiry Timelines from Drug Research to Commercial Launch New Drug Application Documentation and Approval process Cost of Treatment 6.4 Regulatory Framework 6.4.1 Regulatory Overview 6.4.1.1 US FDA 6.4.1.2 EU EMA 6.4.1.3 INDIA CDS JAPAN PMDA Other 7 Challenges & Unmet Needs 7.1 Treatment Pathway Challenges 7.2 Compliance Analysis and Drop-Out Analysis 7.3 Awareness and prevention Gaps 8 Global Chronic Low Back Pain Treatment Market 9 North America Chronic Lower Back Pain Treatment Market 10 Europe Chronic Lower back Pain Treatment Market 11 Asia Pacific Chronic Low Back Pain Treatment Market 12 Latin America Chronic Low Back Pain Treatment Market 13 Middle East & Africa Chronic Lower Back pain Treatment Market 14 Global Chronic Low Back Pain Treatment Market Dynamics 15 Supplier Landscape 16 Global Chronic Low Back Pain Treatment Market – Drug Distribution Model (Additional insights) 17 Payment Options (Additional Insights) For more information about this report visit https://www.researchandmarkets.com/r/wsv29v About ResearchAndMarkets.com ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide the latest data on the international and regional markets, key industry sectors, top companies, new product and trend information. Attachment CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

AmericanChiro -
0
FAQ Answer: Why smartphones and backpacks can hurt kids’ posture NewsNation Now
Back Pain

FAQ Answer: Why smartphones and backpacks can hurt kids’ posture NewsNation Now

AmericanChiro -
0
1234...28Page 3 of 28
© Newspaper WordPress Theme by TagDiv
American Chiropractors Directory and News
Cookies
We serve cookies. If you think that's ok, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings".
Settings Accept all
Cookies
Choose what kind of cookies to accept. Your choice will be saved for one year.
Save Accept all